Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
NCM · Healthcare · Drug Manufacturers - Specialty & Generic
$5.24
+0.58%
Closing price as of 2026-10-28 · Source: TEK2day Finance
Key Metrics
Market Cap
$25.0M
Shares Outstanding
4.8M
Exchange
NCM
Currency
USD
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (2.3M) | (2.8M) | (2.2M) | (3.9M) |
| Net Income | (2.3M) | (2.6M) | (2.2M) | (3.1M) |
| Diluted EPS | $-1.05 | N/A | $-0.43 | $-3.10 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (2.3M) | (5.9M) | (7.7M) | (11.9M) |
| Net Income | (5.0M) | (6.6M) | (9.1M) | (11.7M) |
| Diluted EPS | $-126.00 | $-88.25 | $-82.60 | $-7.16 |